We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

PerkinElmer Introduces Enhanced Protein Analysis and Imaging Portfolio

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

PerkinElmer, Inc. has announced the introduction of five new products at the Human Proteome Organization's (HUPO) 6th Annual World Congress in Seoul, South Korea, Oct. 6-10.

"PerkinElmer's investment into advancing protein analysis and imaging technologies demonstrates our ability to interpret researchers' needs, and to respond with solutions that enable greater productivity and a new level of insight into complex samples," said Robert F. Friel, President and Chief Operating Officer, PerkinElmer, Inc.

ExacTag™ S and ExacTag Analysis Software version 3.0 are additions to the Company's ExacTag product line, recognized as a multiplex platform for quantitative protein expression profiling by mass spectrometry (MS). ExacTag S is the only all-in-one solution for quantifying multiplexed protein expression from serum or plasma.

ExacTag Analysis Software version 3.0 automates communication with the Mascot™ protein search engine, enabling unattended, one-step protein identification and quantitation.

Two new additions to the Phos-tag® line of phosphorylation analysis reagents offer a high degree of sensitivity and selectivity. Phos-tag® Gold is a colorimetric assay for the identification and quantitation of phosphoproteins in solution. Phos-tag® Enrich is for the selective enrichment of phosphoproteins and phosphopeptides in biological samples, such as cell lysates.

New to the Geliance™ family of high-performance bio-imaging systems, the Geliance 1000 Imaging System is one of the most sophisticated technologies in the company's imaging portfolio. With optional advanced illumination design, it captures images of multiplexed 2-D gels for a wide array of white light, fluorescence and chemiluminescence applications in cellular, molecular and cancer research.

The instruments offer top-of-the line optical performance with easy-to-use hardware and software to provide researchers a choice of optics and lighting options.